Reference value of soluble suppression of tumorigenicity 2 (sST2) in healthy community-based Chinese adult population

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041179

Enrollment

Unknown

Registered

2020-12-20

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult population

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Aged >= 18 years; (2) healthy residents; (3) without medications for cardiovascular diseases within 3 months; (4) with normal physical examination; (5) with normal electrocardiogram; (6) with normal echocardiogram; (7) with normal routine laboratory tests.

Exclusion criteria

Exclusion criteria: (1) With history of cardiovascular diseases or medications for cardiovascular diseases within 3 months; (2) with abnormal physical examination, or electrocardiogram, or echocardiogram, or routine laboratory tests; (3) lack of signed informed consent.

Design outcomes

Primary

Measure	Time frame
soluble suppression of tumorigenicity 2 (sST2);	—

Countries

China

Contacts

Public ContactZhang Jian

Fuwai Hospital, Chinese Academy of Medical Sciences

fwzhangjian62@126.com+86 13911102015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026